HighPoint Advisor Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-11,254
| Closed | -$6.52M | – | 1004 |
|
|
2025
Q4 | $6.52M | Sell |
11,254
-962
| -8% | -$544K | 0.14% | 124 |
|
|
2025
Q3 | $5.93M | Sell |
12,216
-126
| -1% | -$58.6K | 0.28% | 58 |
|
|
2025
Q2 | $5M | Sell |
12,342
-2,003
| -14% | -$837K | 0.27% | 65 |
|
|
2025
Q1 | $6.13M | Buy |
14,345
+2,396
| +20% | +$1.3M | 0.36% | 48 |
|
|
2024
Q4 | $6.49M | Buy |
11,949
+53
| +0.4% | +$29.1K | 0.35% | 47 |
|
|
2024
Q3 | $7.36M | Sell |
11,896
-768
| -6% | -$455K | 0.43% | 38 |
|
|
2024
Q2 | $7.79M | Buy |
12,664
+1,237
| +11% | +$709K | 0.47% | 37 |
|
|
2024
Q1 | $6.75M | Sell |
11,427
-49
| -0.4% | -$27.5K | 0.48% | 37 |
|
|
2023
Q4 | $6.58M | Buy |
+11,476
| New | +$5.55M | 0.47% | 36 |
|
|
2022
Q2 | $4.5M | Buy |
+8,101
| New | +$4.46M | 0.49% | 44 |
|
|
2021
Q3 | $4.42M | Sell |
7,738
-17
| -0.2% | -$9.33K | 0.43% | 44 |
|
|
2021
Q2 | $3.91M | Buy |
7,755
+592
| +8% | +$279K | 0.39% | 56 |
|
|
2021
Q1 | $3.43M | Buy |
7,163
+224
| +3% | +$107K | 0.4% | 54 |
|
|
2020
Q4 | $3.4M | Buy |
6,939
+2,163
| +45% | +$1.01M | 0.41% | 52 |
|
|
2020
Q3 | $2.46M | Sell |
4,776
-13
| -0.3% | -$5.37K | 0.44% | 54 |
|
|
2020
Q2 | $1.72M | Buy |
4,789
+144
| +3% | +$48.3K | 0.37% | 59 |
|
|
2020
Q1 | $1.53M | Sell |
4,645
-1,839
| -28% | -$580K | 0.36% | 64 |
|
|
2019
Q4 | $2.19M | Sell |
6,484
-723
| -10% | -$219K | 0.45% | 54 |
|
|
2019
Q3 | $2.12M | Buy |
7,207
+1,528
| +27% | +$438K | 0.47% | 52 |
|
|
2019
Q2 | $1.66M | Buy |
5,679
+2,761
| +95% | +$760K | 0.39% | 61 |
|
|
2019
Q1 | $793K | Buy |
2,918
+377
| +15% | +$93.8K | 0.19% | 104 |
|
|
2018
Q4 | $637K | Buy |
2,541
+166
| +7% | +$38.9K | 0.17% | 139 |
|
|
2018
Q3 | $536K | Buy |
2,375
+22
| +0.9% | +$5.06K | 0.15% | 152 |
|
|
2018
Q2 | $543K | Sell |
2,353
-23
| -1% | -$4.88K | 0.15% | 164 |
|
|
2018
Q1 | $516K | Buy |
2,376
+123
| +5% | +$25.8K | 0.14% | 168 |
|
|
2017
Q4 | $458K | Buy |
2,253
+176
| +8% | +$33.7K | 0.13% | 172 |
|
|
2017
Q3 | $397K | Buy |
2,077
+7
| +0.3% | +$1.27K | 0.12% | 180 |
|
|
2017
Q2 | $365K | Hold |
2,070
| – | – | 0.12% | 189 |
|
|
2017
Q1 | $365K | Buy |
2,070
+42
| +2% | +$6.42K | 0.12% | 189 |
|
|
2016
Q4 | $324K | Buy |
2,028
+79
| +4% | +$11.6K | 0.1% | 208 |
|
|
2016
Q3 | $290K | Sell |
1,949
-1,286
| -40% | -$198K | 0.1% | 222 |
|
|
2016
Q2 | $507K | Buy |
+3,235
| New | +$477K | 0.18% | 144 |
|
Other funds holding TMO
HighPoint Advisor Group's TMO Position: Q1 2026 in Review
HighPoint Advisor Group sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 11,254 shares — an estimated $6.52M sold.
HighPoint Advisor Group first reported a position in TMO in Q2 2016 and held it in 32 quarters. The position peaked at $7.79M in Q2 2024. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- HighPoint Advisor Group reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
- HighPoint Advisor Group sold 11,254 Thermo Fisher Scientific shares in Q1 2026, an estimated $6.52M.
- HighPoint Advisor Group first reported a position in Thermo Fisher Scientific in Q2 2016 and held it in 32 quarters.
- HighPoint Advisor Group's Thermo Fisher Scientific position peaked at $7.79M in Q2 2024.
- 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on HighPoint Advisor Group's 13F filing for Q1 2026, filed 14 May 2026.